Although there have been mixed results with regard to the amount of incretin secretion, a meta-analysis showed that the secretion of GLP-1 and GIP is not reduced in patients with type 2 diabetes compared to their counterparts without diabetes [18,19]
Evidence Summaries and Recommendations From the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome: Lifestyle Management
In other words, it seemed to not impact the medication at all
When comparing GLP-1 programs, look beyond the advertised price and check for licensed medical providers who actively manage your care, a proper health review before prescribing, personalized dosing, ongoing support for side effects and dose adjustments, transparent pricing with no hidden fees, and safe medication sourcing with proper cold-chain shipping where required
Altaf MA, Hao Y, Shu H, Mumtaz MA, Cheng S, Alyemeni MN, et al